Phase 1B General Practice Vaccine Rollout- DoH Update 2 April 2021

Following reports of a specific clotting event following a COVID-19 Vaccination the DoH have released a number of statements

Joint statement from acting Australian Government Chief Medical Officer, Professor Michael  Kidd and Head of the Therapeutic Goods Administration Adj. Professor John Skerritt:

Updated ATAGI statement for healthcare providers:

ATAGI statement for consumers:

TGA statement:

Additional ATAGI statement:

Please Login to post a comment